Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy

Cytotherapy

Volumn 15, Issue 4, 2013, Pages 467-480

  Zhou, Yan ^a   Sun, Maosheng ^a   Li, Hongjun ^a   Yan, Min ^a   He, Zhanlong ^a   Wang, Wenju ^b   Wang, Wanpu ^c   Lu, Shuaiyao ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c First Hospital of Yunnan Province   (China)

Author keywords

differentiation; LMX1A; neuron; Neurturin; Parkinson disease; Rhesus adipose stem cells (rASCs); TH

Indexed keywords

ADENOVIRUS VECTOR; LIM HOMEOBOX TRANSCRIPTION FACTOR 1 ALPHA; NEURTURIN; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENE THERAPY; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STROMA CELL; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; OSTEOBLAST; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHESUS MONKEY; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BEHAVIOR, ANIMAL; CELL DIFFERENTIATION; DOPAMINERGIC NEURONS; FEMALE; GENETIC THERAPY; LIM-HOMEODOMAIN PROTEINS; MACACA MULATTA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MPTP POISONING; NEUROGENESIS; NEURTURIN; OSTEOBLASTS; RANDOM ALLOCATION; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 84875714090     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.01.007     Document Type: Article

References (31)

1. Q. Chen, Y. He, and K. Yang Gene therapy for Parkinson's disease: progress and challenges Curr Gene Ther 5 2005 71 80
2. B. Dass, C.W. Olanow, and J.H. Kordower Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease Neurology 66 2006 89 103
3. F. Guilak, K.E. Lott, H.A. Awad, Q. Cao, K.C. Hicok, and B. Fermor Clonal analysis of the differentiation potential of human adipose-derived adult stem cells J Cell Physiol 206 2006 229 237
4. E. Anghileri, S. Marconi, A. Pignatelli, P. Cifelli, M. Galié, and A. Sbarbati Neuronal differentiation potential of human adipose-derived mesenchymal stem cells Stem Cells Dev 17 2008 909 916
5. T. Scholz, A. Sumarto, A. Krichevsky, and G.R. Evans Neuronal differentiation of human adipose tissue-derived stem cells for peripheral nerve regeneration in vivo Arch Surg 146 2011 666 674
6. E. Andersson, U. Tryggvason, Q. Deng, S. Friling, Z. Alekseenko, and B. Robert Identification of intrinsic determinants of midbrain dopamine neurons Cell 124 2006 393 405
7. J. Cai, A. Donaldson, M. Yang, M.S. German, G. Enikolopov, and L. Iacovitti The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model Stem Cells 27 2009 220 229
8. S. Friling, E. Andersson, L.H. Thompson, M.E. Jönsson, J.B. Hebsgaard, and E. Nanou Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells Proc Natl Acad Sci U S A 106 2009 7613 7618
9. P.T. Kotzbauer, P.A. Lampe, R.O. Heuckeroth, J.P. Golden, D.J. Creedon, and E.M. Johnson Jr. Neurturin, a relative of glial-cell-line-derived neurotrophic factor Nature 384 1996 467 470
10. J.H. Kordower, C.D. Herzog, B. Dass, R.A. Bakay, J. Stansell 3rd, and M. Gasmi Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys Ann Neurol 60 2006 706 715
11. B.A. Horger, M.C. Nishimura, M.P. Armanini, L.C. Wang, and K.T. Poulsen Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons J Neurosci 18 1998 4929 4937
12. T. Nagatsu Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology Essays Biochem 30 1995 15 35
13. D.L. Choi-Lundberg, Q. Lin, Y.N. Chang, Y.L. Chiang, C.M. Hay, and H. Mohajeri Dopaminergic neurons protected from degeneration by GDNF gene therapy Science 275 1997 838 841
14. C. Moriscot, F. de Fraipont, M.J. Richard, M. Marchand, P. Savatier, and D. Bosco Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or micro-environmental manipulation in vitro Stem Cells 23 2005 594 603
15. P. Jenner Functional models of Parkinson's disease: a valuable tool in the development of novel therapies Ann Neurol 64 2008 S16 S29
16. A. Maiorana, A. Fierabracci, and S. Cianfarani Isolation and characterization of omental adipose progenitor cells in children: a potential tool to unravel the pathogenesis of metabolic syndrome Horm Res 72 2009 348 358
17. S. Varon, M. Manthorpe, and R. Adler Cholinergic neuronotrophic factors, I: survival, neurite outgrowth and choline acetyltransferase activity in monolayer cultures from chick embryo ciliary ganglia Brain Res 173 1979 29 45
18. A.R. Doo, S.N. Kim, S.T. Kim, J.Y. Park, S.H. Chung, and B.Y. Choe Bee venom protects SH-SY5Y human neuroblastoma cells from 1-methyl-4- phenylpyridinium-induced apoptotic cell death Brain Res 1429 2012 106 115
19. W. Wang, M. Sun, H. Li, W. Wang, and M. Yan The delivery of tyrosine hydroxylase accelerates the neurorestoration of Macaca Rhesus model of Parkinson's disease provided by Neurturin Neurosci Lett 524 2012 10 15
20. Y.H. Chou, W.S. Huang, T.P. Su, R.B. Lu, F.J. Wan, and Y.K. Fu Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: a SPECT study Eur Neuropsychopharmacol 17 2007 46 52
21. M. Locke, J. Windsor, and P.R. Dunbar Human adipose-derived stem cells: isolation, characterization and applications in surgery ANZ J Surg 79 2009 235 244
22. N.M. Vieira, V. Brandalise, E. Zucconi, M. Secco, B.E. Strauss, and M. Zatz Isolation, characterization, and differentiation potential of canine adipose-derived stem cells Cell Transplant 19 2010 279 289
23. E. Andersson, J.B. Jensen, M. Parmar, F. Guillemot, and A. Björklund Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2 Development 133 2006 507 516
24. A. Abeliovich, and R. Hammond Midbrain dopamine neuron differentiation: factors and fates Dev Biol 304 2007 447 454
25. L. Roybon, T. Hjalt, N.S. Christophersen, J.Y. Li, and P. Brundin Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3 J. Neurosci 28 2008 3644 3656
26. R. Barzilay, T. Ben-Zur, S. Bulvik, E. Melamed, and D. Offen Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells Stem Cells Dev 18 2009 591 601
27. J. Jiang, Z. Lv, Y. Gu, J. Li, L. Xu, and W. Xu Adult rat mesenchymal stem cells differentiate into neuronal-like phenotype and express a variety of neuro-regulatory molecules in vitro Neurosci Res 66 2010 46 52
28. R. Levi-Montalcini, H. Meyer, and V. Hamburger In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo Cancer Res 14 1954 49 57
29. Y. Echelard, D.J. Epstein, B. St-Jacques, L. Shen, J. Mohler, and J.A. McMahon Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity Cell 75 1993 1417 1430
30. J.P. Burbach, and M.P. Smidt Molecular programming of stem cells into mesodiencephalic dopaminergic neurons Trends Neurosci 29 2006 601 603
31. M.P. Smidt, H.S. van Schaick, C. Lanctôt, J.J. Tremblay, J.J. Cox, and A.A. van der Kleij A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons Proc Natl Acad Sci U S A 94 1997 13305 13310